CareDx, Inc (CDNA)
Largest Insider Buys in Sector
CDNA Stock Price History Chart
CDNA Stock Performance
About CareDx, Inc
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing …
Insider Activity of CareDx, Inc
Over the last 12 months, insiders at CareDx, Inc have bought $0 and sold $4.66M worth of CareDx, Inc stock.
On average, over the past 5 years, insiders at CareDx, Inc have bought $240,266 and sold $21.22M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $211,694 was made by Dhingra Ankur (Chief Financial Officer) on 2021‑11‑24.
List of Insider Buy and Sell Transactions, CareDx, Inc
| 2024-12-04 | Sale | Secretary and General Counsel | 1,917 0.0036% | $26.00 | $49,842 | -8.24% | ||
| 2024-11-26 | Sale | director | 5,000 0.0093% | $25.00 | $125,000 | -2.31% | ||
| 2024-11-25 | Sale | Secretary and General Counsel | 1,223 0.0023% | $24.00 | $29,352 | +2.12% | ||
| 2024-11-18 | Sale | Secretary and General Counsel | 5,534 0.0104% | $21.77 | $120,477 | +9.70% | ||
| 2024-08-21 | Sale | See Remarks | 21,557 0.0399% | $32.58 | $702,327 | -21.91% | ||
| 2024-08-20 | Sale | director | 35,552 0.0686% | $33.04 | $1.17M | -19.32% | ||
| 2024-08-20 | Sale | See Remarks | 39,466 0.0765% | $33.17 | $1.31M | -19.32% | ||
| 2024-08-19 | Sale | See Remarks | 34,231 0.0641% | $33.55 | $1.15M | -22.73% | ||
| 2023-10-02 | Sale | See Remarks | 2,818 0.0052% | $6.91 | $19,483 | +48.03% | ||
| 2023-09-05 | Sale | See Remarks | 2,819 0.0054% | $9.49 | $26,762 | +7.49% | ||
| 2023-08-14 | Sale | See Remarks | 576 0.001% | $8.89 | $5,123 | +3.96% | ||
| 2023-08-02 | Sale | See Remarks | 2,819 0.0053% | $11.35 | $31,988 | -13.85% | ||
| 2023-07-13 | Sale | See Remarks | 5,260 0.01% | $10.33 | $54,357 | -3.86% | ||
| 2023-07-13 | Sale | director | 5,000 0.0095% | $10.34 | $51,681 | -3.86% | ||
| 2023-07-03 | Sale | See Remarks | 2,818 0.0052% | $8.48 | $23,901 | +14.49% | ||
| 2023-06-28 | Sale | See Remarks | 14,268 0.0266% | $8.76 | $125,016 | +10.72% | ||
| 2023-06-28 | Sale | director | 2,432 0.0045% | $8.72 | $21,216 | +10.72% | ||
| 2023-06-02 | Sale | See Remarks | 2,819 0.0053% | $8.13 | $22,911 | +14.51% | ||
| 2023-05-02 | Sale | See Remarks | 2,819 0.0054% | $8.12 | $22,898 | +11.00% | ||
| 2023-04-03 | Sale | See Remarks | 2,818 0.0054% | $8.95 | $25,225 | +0.34% |
Insider Historical Profitability
| Maag Peter | director | 330024 0.6153% | $20.84 | 4 | 55 | +57.09% |
| TPG Group Holdings (SBS) Advisors, Inc. | 10 percent owner | 1075090 2.0045% | $20.84 | 1 | 0 | <0.0001% |
| BYERS BROOK H | 751174 1.4006% | $20.84 | 1 | 0 | <0.0001% | |
| KLEINER PERKINS CAUFIELD & BYERS X A LP | 10 percent owner | 751174 1.4006% | $20.84 | 1 | 0 | <0.0001% |
| Gagnon Neil | 10 percent owner | 107940 0.2013% | $20.84 | 48 | 1 | +71.45% |
Institutional Investor Ownership
| ARK Investment Management LLC | $62.1M | 11.26 | 5.86M | -18.5% | -$14.09M | 0.22 | |
| BlackRock | $57.45M | 10.42 | 5.43M | -2.14% | -$1.26M | <0.01 | |
| The Vanguard Group | $45.54M | 8.26 | 4.3M | +4.38% | +$1.91M | <0.01 | |
| State Street | $44.44M | 8.06 | 4.2M | +50.07% | +$14.83M | <0.01 | |
| Bellevue Group | $41.66M | 7.55 | 3.93M | -0.53% | -$220,123.74 | 0.64 |